Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD.sub.3 and hybridoma producing said antibody
US5529922A · kind A · utility
30Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1995 |
| Grant date | Jun 25, 1996 |
| Priority date | — |
| Expiry date | May 22, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides an anti-idiotypic monoclonal antibody, IgG2b subclass, which specifically induces an immune response against the GD.sub.3 ganglioside and specifically binds to the binding site of the R24 antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.